Skip to main content
. 2019 Dec 16;2019(12):CD004290. doi: 10.1002/14651858.CD004290.pub3

3.2. Analysis.

3.2

Comparison 3 Target of rapamycin inhibitors (TOR‐I) versus calcineurin inhibitors (CNI): outcomes at 5 to 8 years post transplant, Outcome 2 Total graft loss.